Potential role of microbiome in oncogenesis, outcome prediction and therapeutic targeting for head and neck cancer

Ester Orlandi, Nicola Alessandro Iacovelli, Vincenzo Tombolini, Tiziana Rancati, Antonella Polimeni, Loris De Cecco, Riccardo Valdagni, Francesca De Felice

Research output: Contribution to journalReview article

Abstract

In the last decade, human microbiome research is rapidly growing involving several fields of clinical medicine and population health. Although the microbiome seems to be linked to all sorts of diseases, cancer has the biggest potential to be investigated. Following the publication of the National Institute of Health - Human Microbiome Project (NIH-HMP), the link between Head and Neck Cancer (HNC) and microbiome seems to be a fast-moving field in research area. However, robust evidence-based literature is still quite scarce. Nevertheless the relationship between oral microbiome and HNC could have important consequences for prevention and early detection of this type of tumors. The aims of the present review are: (i) to discuss current pre-clinical evidence of a role of oral microbiome in HNC; (ii) to report recent developments in understanding the human microbiome's relationship with HNC oncogenesis; (iii) to explore the issue of treatment response and treatment toxicity; (iv) to describe the role of microbiota as potentially modifiable factor suitable for targeting by therapeutics. Further studies are needed to better establish the causal relationship between oral microbiome and HNC oncogenesis. Future trials should continue to explore oral microbiome in order to build the scientific and clinical rationale of HNC preventative and ameliorate treatment outcome.

Original languageEnglish
Article number104453
JournalOral Oncology
Volume99
DOIs
Publication statusPublished - Dec 2019

Fingerprint

Microbiota
Head and Neck Neoplasms
Carcinogenesis
Therapeutics
Clinical Medicine
National Institutes of Health (U.S.)
Research
Publications
Neoplasms

Keywords

  • Biomarkers
  • Head and neck cancer
  • Immunotherapy
  • Microbiome
  • Microbiota
  • Oncogenesis
  • Radiotherapy
  • Toxicity

ASJC Scopus subject areas

  • Oral Surgery
  • Oncology
  • Cancer Research

Cite this

Potential role of microbiome in oncogenesis, outcome prediction and therapeutic targeting for head and neck cancer. / Orlandi, Ester; Iacovelli, Nicola Alessandro; Tombolini, Vincenzo; Rancati, Tiziana; Polimeni, Antonella; De Cecco, Loris; Valdagni, Riccardo; De Felice, Francesca.

In: Oral Oncology, Vol. 99, 104453, 12.2019.

Research output: Contribution to journalReview article

@article{6a3347d27bfa4103a5b47211fe2e793f,
title = "Potential role of microbiome in oncogenesis, outcome prediction and therapeutic targeting for head and neck cancer",
abstract = "In the last decade, human microbiome research is rapidly growing involving several fields of clinical medicine and population health. Although the microbiome seems to be linked to all sorts of diseases, cancer has the biggest potential to be investigated. Following the publication of the National Institute of Health - Human Microbiome Project (NIH-HMP), the link between Head and Neck Cancer (HNC) and microbiome seems to be a fast-moving field in research area. However, robust evidence-based literature is still quite scarce. Nevertheless the relationship between oral microbiome and HNC could have important consequences for prevention and early detection of this type of tumors. The aims of the present review are: (i) to discuss current pre-clinical evidence of a role of oral microbiome in HNC; (ii) to report recent developments in understanding the human microbiome's relationship with HNC oncogenesis; (iii) to explore the issue of treatment response and treatment toxicity; (iv) to describe the role of microbiota as potentially modifiable factor suitable for targeting by therapeutics. Further studies are needed to better establish the causal relationship between oral microbiome and HNC oncogenesis. Future trials should continue to explore oral microbiome in order to build the scientific and clinical rationale of HNC preventative and ameliorate treatment outcome.",
keywords = "Biomarkers, Head and neck cancer, Immunotherapy, Microbiome, Microbiota, Oncogenesis, Radiotherapy, Toxicity",
author = "Ester Orlandi and Iacovelli, {Nicola Alessandro} and Vincenzo Tombolini and Tiziana Rancati and Antonella Polimeni and {De Cecco}, Loris and Riccardo Valdagni and {De Felice}, Francesca",
year = "2019",
month = "12",
doi = "10.1016/j.oraloncology.2019.104453",
language = "English",
volume = "99",
journal = "Oral Oncology",
issn = "1368-8375",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Potential role of microbiome in oncogenesis, outcome prediction and therapeutic targeting for head and neck cancer

AU - Orlandi, Ester

AU - Iacovelli, Nicola Alessandro

AU - Tombolini, Vincenzo

AU - Rancati, Tiziana

AU - Polimeni, Antonella

AU - De Cecco, Loris

AU - Valdagni, Riccardo

AU - De Felice, Francesca

PY - 2019/12

Y1 - 2019/12

N2 - In the last decade, human microbiome research is rapidly growing involving several fields of clinical medicine and population health. Although the microbiome seems to be linked to all sorts of diseases, cancer has the biggest potential to be investigated. Following the publication of the National Institute of Health - Human Microbiome Project (NIH-HMP), the link between Head and Neck Cancer (HNC) and microbiome seems to be a fast-moving field in research area. However, robust evidence-based literature is still quite scarce. Nevertheless the relationship between oral microbiome and HNC could have important consequences for prevention and early detection of this type of tumors. The aims of the present review are: (i) to discuss current pre-clinical evidence of a role of oral microbiome in HNC; (ii) to report recent developments in understanding the human microbiome's relationship with HNC oncogenesis; (iii) to explore the issue of treatment response and treatment toxicity; (iv) to describe the role of microbiota as potentially modifiable factor suitable for targeting by therapeutics. Further studies are needed to better establish the causal relationship between oral microbiome and HNC oncogenesis. Future trials should continue to explore oral microbiome in order to build the scientific and clinical rationale of HNC preventative and ameliorate treatment outcome.

AB - In the last decade, human microbiome research is rapidly growing involving several fields of clinical medicine and population health. Although the microbiome seems to be linked to all sorts of diseases, cancer has the biggest potential to be investigated. Following the publication of the National Institute of Health - Human Microbiome Project (NIH-HMP), the link between Head and Neck Cancer (HNC) and microbiome seems to be a fast-moving field in research area. However, robust evidence-based literature is still quite scarce. Nevertheless the relationship between oral microbiome and HNC could have important consequences for prevention and early detection of this type of tumors. The aims of the present review are: (i) to discuss current pre-clinical evidence of a role of oral microbiome in HNC; (ii) to report recent developments in understanding the human microbiome's relationship with HNC oncogenesis; (iii) to explore the issue of treatment response and treatment toxicity; (iv) to describe the role of microbiota as potentially modifiable factor suitable for targeting by therapeutics. Further studies are needed to better establish the causal relationship between oral microbiome and HNC oncogenesis. Future trials should continue to explore oral microbiome in order to build the scientific and clinical rationale of HNC preventative and ameliorate treatment outcome.

KW - Biomarkers

KW - Head and neck cancer

KW - Immunotherapy

KW - Microbiome

KW - Microbiota

KW - Oncogenesis

KW - Radiotherapy

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=85074333875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074333875&partnerID=8YFLogxK

U2 - 10.1016/j.oraloncology.2019.104453

DO - 10.1016/j.oraloncology.2019.104453

M3 - Review article

AN - SCOPUS:85074333875

VL - 99

JO - Oral Oncology

JF - Oral Oncology

SN - 1368-8375

M1 - 104453

ER -